Business:
Novel treatments for gastrointestinal diseases and disorders
Drug notes:
Also NDA errosive GERD, heartburn, Clin3 heartburn in non-erosive GERD, different dosing Clin2 heartburn in non-erosive GERD, Clin2 eosinophilic esophagitis
About:
Phathom Pharmaceuticals is dedicated to improving treatments for gastrointestinal (GI) diseases. They focus on developing innovative therapies for acid-related disorders like ulcers and heartburn. One key area of their research is the development of new proton pump inhibitors – a class of drugs that reduce stomach acid production. While there are existing PPIs on the market, Phathom is investigating more effective and potentially longer-lasting options. This could lead to improved patient outcomes and potentially reduce the need for frequent medication use.
Territory Sales Representative Dallas, TX|5 days ago
Territory Sales Representative New Orleans, LA|5 days ago
Territory Sales Representative Bronx, NY|5 days ago
Territory Sales Representative Portland, OR|5 days ago
Medical Science Liaison / Senior Medical Science L... United States|19 days ago
Medical Science Liaison / Senior Medical Science L... United States|19 days ago
Regional Sales Manager - IN/IL United States|31 days ago
Regional Sales Manager - Northwest (WA, OR, UT, ID... United States|31 days ago
********* ***** ************** **** *****, **|41 days ago
Territory Sales Representative Livonia, MI|41 days ago
********* ***** ************** *********, **|42 days ago